Successful erlotinib rechallenge after both gefitinib- and erlotinib-induced interstitial lung diseases

類似資料

• Successful treatment of non-small-cell lung cancer with afatinib and a glucocorticoid following gefitinib- and erlotinib-induced interstitial lung disease: A case report
  著者:: Tani, Tetsuo, 等
  出版事項: (2016)
• Successful Osimertinib Rechallenge with Steroid Therapy after Osimertinib-induced Interstitial Lung Disease
  著者:: Kiriu, Tatsunori, 等
  出版事項: (2017)
• Successful Erlotinib Treatment for a Patient with Gefitinib-Related Hepatotoxicity and Lung Adenocarcinoma Refractory to Intermittently Administered Gefitinib
  著者:: Nagano, Tatsuya, 等
  出版事項: (2011)
• Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
  著者:: Uruga, Hironori, 等
  出版事項: (2018)
• Successful rechallenge with reduced dose of erlotinib in a patient with lung adenocarcinoma who developed erlotinib-associated leukocytoclastic vasculitis: A case report
  著者:: SU, BO-AN, 等
  出版事項: (2012)